Blue Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Blue Trust's ABBV Position: Q3 2026 in Review
Blue Trust reduced its AbbVie (ABBV) stake by 8.6% in Q3 2026, selling an estimated $930K and leaving 38,455 shares worth $10.1M. The position accounts for 0.11% of the portfolio, ranked #67.
Blue Trust first reported a position in ABBV in Q2 2022 and has held it in 18 quarters since. The position peaked at $10.8M in Q3 2025. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Blue Trust held 38,455 shares of AbbVie worth $10.1M as of Q3 2026.
- Blue Trust sold 3,627 AbbVie shares in Q3 2026, an estimated $930K.
- AbbVie made up 0.11% of Blue Trust's portfolio in Q3 2026, its #67 holding.
- Blue Trust first reported a position in AbbVie in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's AbbVie position peaked at $10.8M in Q3 2025.
- 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.